Optimisation of atorvastatin dosing for the treatment of familial hypercholesterolemia in paediatric patients

被引：0
|
作者：
D'Agate, Salvatore [1 ,2 ]
Velickovic, Peter [1 ,2 ]
Buonuomo, Paola Sabrina [3 ]
Rana, Ippolita [3 ]
Bartuli, Andrea [3 ]
Biondi, Isabella [4 ]
Ciabattini, Marco [4 ]
Pontrelli, Giuseppe [4 ]
Goffredo, Bianca Maria [5 ]
Della Pasqua, Oscar [1 ,2 ]
机构：
[1] UCL, Clin Pharmacol & Therapeut Grp, London, England
[2] CNR, Ist Applicaz Calcolo, Rome, Italy
[3] Osped Pediat Bambino Gesu, Rare Dis & Med Genet Unit, Rome, Italy
[4] Osped Pediat Bambino Gesu, Clin Trials Ctr, Rome, Italy
[5] Osped Pediat Bambino Gesu, Metab Pathol Lab, Rome, Italy
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OC114
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [1] Effects of atorvastatin in patients with homozygous familial hypercholesterolemia
    Postiglione, A
    Montefusco, S
    Pauciullo, P
    Mancini, M
    Piliego, T
    ATHEROSCLEROSIS, 1999, 147 (02) : 423 - 424
  • [2] Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin
    Bo, M
    Nicolello, MT
    Fiandra, U
    Mercadante, G
    Piliego, T
    Fabris, F
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2001, 11 (01) : 17 - 24
  • [3] ZD4522 is superior to atorvastatin in the treatment of patients with heterozygous familial hypercholesterolemia
    Stein, E
    Strutt, KL
    Miller, E
    Southworth, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 292A - 292A
  • [4] Effect of atorvastatin on endothelial function in patients with familial hypercholesterolemia
    Balakhonova, TV
    Pogorelova, OA
    Susekov, AV
    Kobylyansky, AG
    Kuznetsova, TV
    Tvorogova, MG
    Masenko, VP
    Titov, VN
    Kukharchuk, VV
    Atkov, OY
    KARDIOLOGIYA, 2002, 42 (01) : 15 - 21
  • [5] Atorvastatin (lipitor) in the treatment of patients with hypercholesterolemia
    Delaroudis, S
    Slavakis, A
    Tzoiti, M
    Kyroudi, A
    Balaris, C
    Sarris, J
    Giannoulis, M
    Kita, M
    Sofianou, D
    Hatzikonstantinou, H
    Avramides, A
    ATHEROSCLEROSIS, 1999, 144 : 186 - 186
  • [6] Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin
    Homma, Koichiro
    Homma, Yasuhiko
    Yoshida, Tadashi
    Ozawa, Hideki
    Shiina, Yutaka
    Wakino, Shu
    Hayashi, Koichi
    Itoh, Hiroshi
    Hori, Shingo
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (02) : 210 - 216
  • [7] Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia
    Stein, EA
    Strutt, K
    Southworth, H
    Diggle, PJ
    Miller, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (11): : 1287 - 1293
  • [8] Design of a study comparing toruetrapib/atorvastatin with atorvastatin alone on atherosclerosis in patients with Familial Hypercholesterolemia
    Kastelein, JJP
    Bots, ML
    Riley, WA
    Evans, GW
    Meijer, R
    Revkin, JH
    Raszewska, J
    Shear, CL
    Thuren, T
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 51 - 52
  • [9] CHANGES IN PLASMA LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH POLYGENIC HYPERCHOLESTEROLEMIA, FAMILIAL COMBINED HYPERLIPOPROTEINEMIA, AND FAMILIAL HYPERCHOLESTEROLEMIA AFTER ATORVASTATIN
    Muinjonov, B.
    Giyazitdinova, E.
    ATHEROSCLEROSIS, 2016, 252 : E45 - E45
  • [10] Efficacy and safety of combination torcetrapib/atorvastatin versus atorvastatin alone in patients with heterozygous familial hypercholesterolemia
    Revkin, James
    Ose, Leiv
    Marais, A. David
    Pretorius, Matty
    Viljoen, Johann
    Burgess, Lesley
    Lan, Shu-Ping
    Thuren, Tom
    Shear, Charles
    CIRCULATION, 2006, 114 (18) : 318 - 318
12345